文献速递胃肠外科围术期管理与 ERAS

进展期胃癌根治术后早期复发中结外扩展的预后意义

Prognostic significance of extranodal extension for early postoperative recurrence following curative surgery in advanced gastric cancer.
PubMed 文献 · Surg Endosc · 2025-11-17

本研究基于244例根治性胃切除后接受辅助化疗的进展期胃癌患者注册数据,评估结外扩展(ENE)与最大转移淋巴结(LLN)尺寸对早期复发的影响。多因素分析显示仅ENE是早期复发的独立危险因素(HR 3.34,p=0.007),LLN尺寸在多因素调整后失去预后意义。ENE也是5年无复发生存和总生存的独立预后因素。

要点

  • ENE阳性是进展期胃癌根治术后早期复发的独立危险因素(HR 3.34)。
  • LLN尺寸≥5mm在单因素中预测早期复发,但多因素调整后无统计学意义。
  • ENE阳性与更高T分期、N分期及更大LLN尺寸显著相关。

核心结论

  • ENE是进展期胃癌早期复发和长期生存的强独立预后因素。
  • LLN尺寸虽与肿瘤侵袭性相关,但多因素调整后失去预后意义。
  • ENE有助于风险分层和术后管理策略制定。

研究设计与样本

  • 回顾性注册研究,纳入244例根治性胃切除后接受辅助化疗的进展期胃癌患者。
  • 平均年龄61.4±10.7岁,男性占75.0%。
  • 采用Cox比例风险模型评估ENE和LLN尺寸与肿瘤学结局的关联。

主要发现

  • ENE阳性与更高T分期、N分期及更大LLN尺寸显著相关。
  • 单因素分析中,ENE预测早期复发HR 5.43(p<0.001),LLN尺寸≥5mm HR 3.52(p=0.001)。
  • 多因素分析中,仅ENE是早期复发的独立危险因素(HR 3.34,p=0.007)。
  • 5年RFS的独立预后因素包括ENE阳性(HR 2.15,p=0.003)、更高T分期(HR 1.93,p=0.044)和晚期N分期(HR 2.59,p=0.007)。
  • ENE阳性是OS的独立预后因素(HR 2.04,p=0.015)。

临床怎么用

  • 对ENE阳性的进展期胃癌根治术后患者,应加强早期复发监测和个体化术后管理。
  • LLN尺寸不宜单独作为早期复发的风险分层指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: More than half of recurrences in advanced gastric cancer (AGC) occur within 2 years of curative surgery. Identifying predictive factors for early recurrence is crucial for improving patient survival. We aimed to evaluate the impact of extranodal extension (ENE) and the largest metastatic lymph-node (LLN) size on early recurrence in patients with AGC. METHODS: Data of patients who underwent adjuvant chemotherapy after radical gastrectomy were extracted from the registry. Clinicopathological characteristics were compared according to ENE status and LLN size. Cox proportional hazard models were used to assess associations between ENE, LLN size, and oncologic outcomes. RESULTS: This study included 244 patients (mean age, 61.4 ± 10.7 years; male, 75.0%). ENE positivity was significantly associated with higher T and N stages, and larger LLN size. In the univariable analysis, ENE (hazard ratio [HR]: 5.43, p < 0.001) and LLN size ≥ 5 mm (HR: 3.52, p = 0.001) were significant predictors of early recurrence. However, in the multivariable analysis, only ENE was an independent risk factor (HR: 3.34, p = 0.007). For 5-year RFS, ENE positivity (HR: 2.15, p = 0.003), higher T stage (HR: 1.93, p = 0.044), and advanced N stage (HR: 2.59, p = 0.007) were independent prognostic factors, whereas LLN size lost statistical significance. Similarly, ENE positivity remained an independent prognostic factor for OS (HR: 2.04, p = 0.015). CONCLUSION: ENE is a strong independent prognostic factor for early recurrence and long-term survival in AGC, whereas LLN size, despite its association with tumour aggressiveness, loses prognostic significance after multivariable adjustment, highlighting ENE's clinical relevance in risk stratification and postoperative management strategies.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Jeong SA, Kim S, Kim JH, et al. Prognostic significance of extranodal extension for early postoperative recurrence following curative surgery in advanced gastric cancer. Surg Endosc. 2025. PMID: 41249532. doi:10.1007/s00464-025-12372-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。